Please Wait
Applying Filters...
menu
    • menu
    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Faran Shimi Naltrexone Methobromide

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Methylnaltrexone Bromide

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 8,699Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 2ACTAVIS LLC

    02 1MYLAN LABS LTD

    03 1SALIX

    04 3SALIX PHARMS

    05 1US GENERICS, STERILES

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    PharmaCompass
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    01

    ACTAVIS LLC

    Ireland
    2024 ACI Convention
    Not Confirmed
    arrow

    ACTAVIS LLC

    Ireland
    arrow
    2024 ACI Convention
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Ireland
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    RLD : No

    TE Code : AP

    METHYLNALTREXONE BROMIDE

    Brand Name : METHYLNALTREXONE BROMIDE

    Dosage Form : SOLUTION;SUBCUTANEOUS

    Dosage Strength : 8MG/0.4ML (8MG/0.4ML)

    Approval Date : 2024-08-26

    Application Number : 208112

    RX/OTC/DISCN : RX

    RLD : No

    TE Code : AP

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    ACTAVIS LLC

    Ireland
    2024 ACI Convention
    Not Confirmed
    arrow

    ACTAVIS LLC

    Ireland
    arrow
    2024 ACI Convention
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Ireland
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    RLD : No

    TE Code : AP

    METHYLNALTREXONE BROMIDE

    Brand Name : METHYLNALTREXONE BROMIDE

    Dosage Form : SOLUTION;SUBCUTANEOUS

    Dosage Strength : 12MG/0.6ML (12MG/0.6ML)

    Approval Date : 2024-08-26

    Application Number : 208112

    RX/OTC/DISCN : RX

    RLD : No

    TE Code : AP

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    SALIX PHARMS

    U.S.A
    2024 ACI Convention
    Not Confirmed
    arrow

    SALIX PHARMS

    U.S.A
    arrow
    2024 ACI Convention
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    RLD : Yes

    TE Code :

    METHYLNALTREXONE BROMIDE

    Brand Name : RELISTOR

    Dosage Form : SOLUTION;SUBCUTANEOUS

    Dosage Strength : 12MG/0.6ML (12MG/0.6ML)

    Approval Date : 2008-04-24

    Application Number : 21964

    RX/OTC/DISCN : RX

    RLD : Yes

    TE Code :

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    04

    SALIX PHARMS

    U.S.A
    2024 ACI Convention
    Not Confirmed
    arrow

    SALIX PHARMS

    U.S.A
    arrow
    2024 ACI Convention
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    RLD : Yes

    TE Code : AP

    METHYLNALTREXONE BROMIDE

    Brand Name : RELISTOR

    Dosage Form : SOLUTION;SUBCUTANEOUS

    Dosage Strength : 8MG/0.4ML (8MG/0.4ML)

    Approval Date : 2010-09-27

    Application Number : 21964

    RX/OTC/DISCN : RX

    RLD : Yes

    TE Code : AP

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    05

    SALIX PHARMS

    U.S.A
    2024 ACI Convention
    Not Confirmed
    arrow

    SALIX PHARMS

    U.S.A
    arrow
    2024 ACI Convention
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    RLD : Yes

    TE Code : AP

    METHYLNALTREXONE BROMIDE

    Brand Name : RELISTOR

    Dosage Form : SOLUTION;SUBCUTANEOUS

    Dosage Strength : 12MG/0.6ML (12MG/0.6ML)

    Approval Date : 2010-09-27

    Application Number : 21964

    RX/OTC/DISCN : RX

    RLD : Yes

    TE Code : AP

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    06

    SALIX

    U.S.A
    2024 ACI Convention
    Not Confirmed
    arrow

    SALIX

    U.S.A
    arrow
    2024 ACI Convention
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    RLD : Yes

    TE Code :

    METHYLNALTREXONE BROMIDE

    Brand Name : RELISTOR

    Dosage Form : TABLET;ORAL

    Dosage Strength : 150MG

    Approval Date : 2016-07-19

    Application Number : 208271

    RX/OTC/DISCN : RX

    RLD : Yes

    TE Code :

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    07

    MYLAN LABS LTD

    U.S.A
    2024 ACI Convention
    Not Confirmed
    arrow

    MYLAN LABS LTD

    U.S.A
    arrow
    2024 ACI Convention
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    RLD :

    TE Code :

    METHYLNALTREXONE BROMIDE

    Brand Name : METHYLNALTREXONE BROMIDE

    Dosage Form : INJECTABLE;SUBCUTANEOUS

    Dosage Strength : 12MG/0.6ML

    Approval Date :

    Application Number : 208592

    RX/OTC/DISCN :

    RLD :

    TE Code :

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    08

    US GENERICS, STERILES

    Country
    2024 ACI Convention
    Not Confirmed
    arrow

    US GENERICS, STERILES

    Country
    arrow
    2024 ACI Convention
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Country
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    RLD :

    TE Code :

    METHYLNALTREXONE BROMIDE

    Brand Name : METHYLNALTREXONE BROMIDE

    Dosage Form : SOLUTION;SUBCUTANEOUS

    Dosage Strength : 12MG/0.6ML

    Approval Date :

    Application Number : 208038

    RX/OTC/DISCN :

    RLD :

    TE Code :

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF